Financial results - GERAS BIOLEGACY S.R.L.

Financial Summary - Geras Biolegacy S.r.l.
Unique identification code: 41264840
Registration number: J15/1120/2019
Nace: 125
Sales - Ron
4.246
Net Profit - Ron
3.585
Employees
Open Account
Company Geras Biolegacy S.r.l. with Fiscal Code 41264840 recorded a turnover of 2021 of 4.246, with a net profit of 3.585 and having an average number of employees of - . The company operates in the field of CAEN Ver.3: Cultivarea altor pomi fructiferi, a arbuştilor fructiferi, căpşunilor şi a nuciferelor; CAEN Ver.2: Cultivarea fructelor arbustilor fructiferi, capsunilor, nuciferilor si a altor pomi fructiferi; having the NACE code 125.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Geras Biolegacy S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 0 1.613 4.269 - - -
Total Income - EUR - - - - 0 1.613 4.269 - - -
Total Expenses - EUR - - - - 562 3.109 539 - - -
Gross Profit/Loss - EUR - - - - -562 -1.496 3.731 - - -
Net Profit/Loss - EUR - - - - -562 -1.543 3.605 - - -
Employees - - - - 0 0 0 - - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 170.8%, from 1.613 euro in the year 2020, to 4.269 euro in 2021. The Net Profit increased by 3.605 euro, from 0 euro in 2020, to 3.605 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Geras Biolegacy S.r.l.

Rating financiar

Financial Rating -
GERAS BIOLEGACY S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Geras Biolegacy S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Geras Biolegacy S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Geras Biolegacy S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Geras Biolegacy S.r.l. - CUI 41264840

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 138 152 120 - - -
Current Assets - - - - 227 394 2.158 - - -
Inventories - - - - 128 83 82 - - -
Receivables - - - - 0 264 420 - - -
Cash - - - - 99 47 1.657 - - -
Shareholders Funds - - - - -519 -2.053 1.598 - - -
Social Capital - - - - 42 41 40 - - -
Debts - - - - 884 2.599 680 - - -
Income in Advance - - - - 0 0 0 - - -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "125 - 125"
CAEN Financial Year 125
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.158 euro in 2021 which includes Inventories of 82 euro, Receivables of 420 euro and cash availability of 1.657 euro.
The company's Equity was valued at 1.598 euro, while total Liabilities amounted to 680 euro. Equity increased by 3.605 euro, from -2.053 euro in 2020, to 1.598 in 2021.

Risk Reports Prices

Reviews - Geras Biolegacy S.r.l.

Comments - Geras Biolegacy S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.